Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Non-cash Items (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Non-cash Items for 3 consecutive years, with $655277.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 318.26% to $655277.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $655277.0 through Dec 2025, up 318.26% year-over-year, with the annual reading at $655277.0 for FY2025, 318.26% up from the prior year.
  • Non-cash Items hit $655277.0 in Q4 2025 for Mangoceuticals, roughly flat from $654444.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.0 million in Q2 2024 to a low of $135833.0 in Q3 2024.
  • Historically, Non-cash Items has averaged $560202.6 across 3 years, with a median of $640194.0 in 2023.
  • Biggest YoY gain for Non-cash Items was 381.8% in 2025; the steepest drop was 92.38% in 2025.
  • Year by year, Non-cash Items stood at $176666.0 in 2023, then dropped by 11.32% to $156666.0 in 2024, then soared by 318.26% to $655277.0 in 2025.
  • Business Quant data shows Non-cash Items for MGRX at $655277.0 in Q4 2025, $654444.0 in Q3 2025, and $150833.0 in Q2 2025.